News

Paris, France - Enoxaparin (Lovenox, Sanofi-Aventis) seems to be associated with a lower risk of cardiovascular outcomes compared with unfractionated heparin (UFH) in patients with STEMI ...
In this nonrandomized, retrospective study, minor (but not major) bleeding was significantly more common with enoxaparin than with UFH among patients with severe renal insufficiency. In December ...
Lovenox is a prescription drug used to treat or prevent certain types of blood clots. Learn how to lower long-term costs, and more.
Watson Pharmaceuticals said that Amphastar Pharmaceuticals' abbreviated new drug application for enoxaparin sodium injection in the 100-mg/mL and 150-mg/mL strengths received approval from the FDA.
The complexity hasn't deterred generics makers from promising to launch their versions, and soon. Novartis has been saying that it's confident of eventual FDA approval of its form of Lovenox ...
Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi ...
Sanofi-aventis Comments on Injunctive Relief Hearing Regarding Lovenox® Paris, France - Aug 26, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. District Court ...
The patient was given two doses of the blood thinner Lovenox in March at Adventist Health Simi Valley over just two hours instead of the recommended 12-hour separation, said California Department ...
Doctors in Europe can continue to use Sanofi-Aventis SA's <SASY.PA> heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European Medicines ...
The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding and ...
CONTACT: Investor Relations: Teva Pharmaceutical Industries Ltd. Elana Holzman, 972 (3) 926-7554 or Teva North America Kevin Mannix, 215-591-8912 or Media: Teva Pharmaceutical Industries Ltd ...